Metraipolis › archive › dc_89669dc2bf8f

Evolving non-invasive biomarkers in NSCLC immunotherapy: integrating liquid biopsy and multi-omics profiling for precision oncology — Europe PMC PMID:42582172

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42582172
DOI: 10.3389/fimmu.2026.1900900
License (as archived): solo-consultazione
Archived: 2026-10-17T11:22:13.845Z
SHA-256 of the archived text: 1ac5b61a493661b47c10b6a6721136e19bc66d67ac281e831a440ec78db5c6ab
Stable URL of this page: https://metraipolis.com/documento/dc_89669dc2bf8f

How to cite

Evolving non-invasive biomarkers in NSCLC immunotherapy: integrating liquid biopsy and multi-omics profiling for precision oncology — Europe PMC PMID:42582172 — Europe PMC (en), https://europepmc.org/article/MED/42582172 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_89669dc2bf8f (Metraipolis archive dc_89669dc2bf8f, sha256 1ac5b61a493661b47c10b6a6721136e19bc66d67ac281e831a440ec78db5c6ab)

BibTeX

@misc{dc89669dc2bf8f,
  title = {Evolving non-invasive biomarkers in NSCLC immunotherapy: integrating liquid biopsy and multi-omics profiling for precision oncology — Europe PMC PMID:42582172},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42582172},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_89669dc2bf8f; sha256 1ac5b61a493661b47c10b6a6721136e19bc66d67ac281e831a440ec78db5c6ab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42582172. Agents can read the archived copy with the MCP tool read_document.